Marché européen de la chirurgie du cancer du poumon – Tendances et prévisions du secteur jusqu’en 2029

Demande de table des matières Demande de table des matières Parler à un analysteParler à un analyste Acheter maintenantAcheter maintenant Renseignez-vous avant d'acheterRenseignez-vous avant Exemple de rapport gratuitExemple de rapport gratuit

Marché européen de la chirurgie du cancer du poumon – Tendances et prévisions du secteur jusqu’en 2029

  • Medical Devices
  • Publish Reports
  • Oct 2022
  • Europe
  • 350 Pages
  • Nombre de tableaux : 51
  • Nombre de figures : 40

Europe Lung Cancer Surgery Market

Taille du marché en milliards USD

TCAC :  % Diagram

Diagram Période de prévision
2022 –2029
Diagram Taille du marché (année de référence)
USD 907.49 Million
Diagram Taille du marché (année de prévision)
USD 1,356.92 Million
Diagram TCAC
%
DiagramPrincipaux acteurs du marché
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5 < /li>

>Marché européen de la chirurgie du cancer du poumon, par type de produit (instruments chirurgicaux, système de surveillance et de visualisation, équipement endochirurgical, systèmes de chirurgie thoracique assistée par robot et autres), procédure chirurgicale (thoracotomie et chirurgie mini-invasive), type de patient (homme et femme), utilisateur final (hôpitaux, centres de chirurgie ambulatoire, laboratoires universitaires et de recherche, centres spécialisés de soins contre le cancer et autres), canal de distribution (appel d'offres direct, ventes au détail, ventes en ligne et autres) - Tendances et prévisions de l'industrie jusqu'en 2029.

Marché de la chirurgie du cancer du poumon

Analyse et perspectives du marché européen de la chirurgie du cancer du poumon 

La chirurgie cunéiforme est une procédure utilisée pour retirer le cancer du poumon ainsi qu'une petite quantité de tissu sain. La résection segmentaire fait référence à l'ablation d'une plus grande partie du poumon. Une lobectomie est une procédure visant à retirer l'un des cinq lobes du poumon. La pneumonectomie est l'ablation chirurgicale de l'ensemble du poumon.

Marché de la chirurgie du cancer du poumon

Marché de la chirurgie du cancer du poumon

Le marché européen de la chirurgie du cancer du poumon devrait connaître une croissance du marché au cours de la période de prévision de 2022 à 2029. Data Bridge Market Research analyse que le marché croît avec un TCAC de 5,0 % au cours de la période de prévision de 2022 à 2029 et devrait atteindre 1 356,92 millions USD d'ici 2029 contre 907,49 millions USD en 2021.

Rapport métrique

Détails

Période de prévision

2022 à 2029

Année de base

2021

Années historiques

2020 (Personnalisable 2019-2014)

Unités quantitatives

Chiffre d'affaires en millions USD

Segments couverts

Par type de produit (instruments chirurgicaux, système de surveillance et de visualisation, équipement endochirurgical, systèmes de chirurgie thoracique assistée par robot et autres), procédure chirurgicale (thoracotomie et chirurgie mini-invasive ), type de patient (homme et femme), utilisateur final (hôpitaux, centres de chirurgie ambulatoire , laboratoires universitaires et de recherche, centres spécialisés dans le traitement du cancer et autres), canal de distribution (appel d'offres direct, vente au détail, vente en ligne et autres)

Pays couverts

Allemagne, France, Royaume-Uni, Italie, Espagne, Pays-Bas, Russie, Belgique, Suisse, Turquie, Reste de l'Europe

Acteurs du marché couverts

Les principales entreprises présentes sur le marché sont Ackermann, KLS Martin Group, Wexler Surgical, Lepu Medical Technology(Beijing)Co.,Ltd., Intuitive Surgical, FusionKraft, Surgical Holdings, GerMedUSA, Medtronic, Accuray Incorporated, Teleflex Incorporated, KARL STORZ SE & Co. KG, TROKAMED GmbH, Richard Wolf GmbH, FUJIFILM Holdings America Corporation, Johnson & Johnson Services, Inc, Olympus Corporation entre autres.

Définition du marché

Depending on the kind, location, and stage of their lung cancer as well as any other medical issues, certain people may be candidates for lung cancer surgery. This kind of surgery is used to treat lung cancer. It involves removing the tumour, some lung tissue around it, and frequently some lymph nodes as well. When lung cancer is limited and not anticipated to have spread, surgery to remove the tumour is thought to be the best option. This includes carcinoid tumours and non-small cell lung cancer in its early stages.

Lung Cancer Surgery Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers

  • Increased Prevalence Of Lung Cancer Diseases

Lung cancer is the most common leading cause of death in men and women globally. The incidence and mortality from lung cancer increasing globally due to the commencement of the tobacco epidemic in various countries and populations in the developing world. Lung cancer, including trachea and bronchus cancer, is widely regarded as a threat to global health, causing a heavy burden on individuals and families. Lung cancer is a malignant tumor characterized by the uncontrolled growth of cell tissues in the lung. It is the second most commonly diagnosed and has the highest mortality rate of all cancers in both men and women. According to the GLOBOCAN, Lung cancer is the most common malignancy diagnosed worldwide, with an age-standardized incidence rate of 22.5 per 100,000 person-years. Men have a higher chance of developing lung cancer than women. However, since the middle of the 1990s, male patient incidence rates have decreased in most developed countries, while female patient incidence rates have steadily grown.

  • Technological Advancement In The Field Of Healthcare

Technology advancement are of immense importance in the surgery of lung cancer. The importance of technological advancement has now taken almost every aspect of our lives. However, the most significant benefits are due to technological advances in health care. By developing new methodologies for treatment, the health system's technology becomes more effective. Recent technological advances have saved millions of lives and increased the quality of life.

In the people of all ages lung cancer is a well-known and prevalent disorder. The cutting –edge technology helps in providing better options for screening the disease. Thus, introduction of technological advanced products for the treatment of lung cancer acts as a driver for the growth of the market

  • Increased Awareness Regarding The Benefits

The growing awareness programs of lung cancer by non-profit, private and public organization is leveraging to boost the market growth. These initiatives aim to reducing stigma and prejudice, prevent diseases and promoting research.

The above statement show that awareness among the population regarding lung cancer has increased as there are many awareness programs by different organizations, people know about lung cancer that can be cured if diagnosed at early stages. Thus, raising awareness among populations is acting as a driver for the Europe lung cancer surgery market.

Opportunities

  • Rise of Minimally Invasive Techniques in Lung Cancer Surgery

Surgery is the standard of therapy for early-stage non-small cell lung cancer (NSCLC). Minimally invasive surgery (MIS), is now preferred to conventional open surgery. It has been shown that MIS procedures like video-assisted thoracoscopic surgery (VATS) and robot-assisted thoracoscopic surgery (RATS) lessen postoperative problems and decrease hospital stays. Therefore, there are launches of new minimally invasive techniques.

Growing demand for minimally invasive technique is also beneficial for further economic growth and healthcare sector growth and it is primarily fruitful as it significantly affects the development of better and advanced medical technique in the market. Thereby surge in minimally techniques in lung cancer surgery is a greater opportunity for the Europe lung cancer surgery market.

Restraints/Challenges

However, the barriers to the lung cancer surgery techniques and high cost of lung cancer surgery process in some of the regions may impede the less growth of the lung cancer surgery hampering the growth of the market. Additionally, high competition in medical technology industries and long lead time for the overseas qualification can be the challenging factors for the growth of the market

This lung cancer surgery market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on lung cancer surgery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

 COVID-19 Impact on Lung Cancer Surgery Market

All industries, including healthcare, medical device services, automotive, pharmaceutical and many more have been severely disrupted by the new coronavirus. The epidemic has caused supply chain disruptions and shutdowns of large-scale manufacturing, which have had an effect on the economics of almost every country in the world. The non-small cell lung cancer diagnostic sector was also impacted by the pandemic. Patients choose to stay at home rather than receive diagnosis and treatment out of fear of contracting the virus. The healthcare system changed its emphasis on containing COVID-19 as cases increased, delaying the diagnosis and treatment of other chronic illnesses like cancer in the process. As a result, the pandemic scenario is predicted to have a negative effect on the lung cancer diagnostics industry. As a result, COVID-19 patients occupied all available beds in hospitals and clinics, whereas lung cancer patients received less attention. Additionally, the market growth has been affected by clinic accessibility issues, social exclusion and population lockdown, all of which slow down referrals and patient flow.

The market for lung cancer surgery, however, may see growth due to a slight easing in COVID-19 cases, which will result in increased demand for lung cancer diagnosis and surgery with patients coming forward to clinics and hospitals for treatment. Cases of COVID-19 are declining in number and vaccination against it is increasing across the Europe.

 Recent Development

  • In May 2021, Olympus announced today the market launch of the FDA 510(k)-cleared BF-UC190F endobronchial ultrasound (EBUS) bronchoscope, the newest addition to its robust EBUS portfolio of devices for minimally invasive lung cancer diagnosis and staging via needle biopsy.

Europe Lung Cancer Surgery Market Scope

Europe lung cancer surgery market is segmented into product type, surgical procedure, patient type, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Product Type

  • Surgical Instruments
  • Monitoring & Visualizing System
  • Endosurgical Equipment
  • Robotic-Assisted Thoracic Surgery Systems 
  • Others

On the basis of product type, the Europe lung cancer surgery market is segmented into surgical instruments, monitoring & visualizing system, endosurgical equipment, robotic-assisted thoracic surgery systems and others.

Surgical Procedure

  • Thoracotomy
  • Minimally Invasive Surgery

On the basis of surgical procedure, the Europe lung cancer surgery market is segmented into thoracotomy and minimally invasive surgery.

Patient Type

  • Male
  • Female

On the basis of patient type, the Europe lung cancer surgery market is segmented into male and female.

End User

  • Hospitals
  • Ambulatory & Surgical Centers
  • Academic & Research Institutes
  • Specialty Cancer Care Center
  • Others

Sur la base de l'utilisateur final, le marché européen de la chirurgie du cancer du poumon est segmenté en hôpitaux, centres ambulatoires et chirurgicaux, instituts universitaires et de recherche, centres spécialisés dans les soins contre le cancer et autres.

Canal de distribution

  • Appel d'offres direct
  • Ventes au détail
  • Ventes en ligne
  • Autres

Marché de la chirurgie du cancer du poumon

Sur la base du canal de distribution, le marché européen de la chirurgie du cancer du poumon est segmenté en appels d'offres directs, ventes au détail, ventes en ligne et autres.

Analyse/perspectives régionales du marché de la chirurgie du cancer du poumon         

Le marché européen de la chirurgie du cancer du poumon est analysé et des informations et tendances sur la taille du marché sont fournies par pays, type de produit, procédure chirurgicale, type de patient, utilisateur final et canal de distribution comme référencé ci-dessus.

Le marché européen de la chirurgie du cancer du poumon comprend les pays suivants : Allemagne, France, Royaume-Uni, Italie, Espagne, Pays-Bas, Russie, Belgique, Suisse, Turquie et reste de l'Europe.

L'Allemagne domine le marché européen de la chirurgie du cancer du poumon en termes de part de marché et de chiffre d'affaires et continuera à accroître sa domination au cours de la période de prévision. Cela est dû au besoin croissant de vérification et de validation des processus chirurgicaux oncologiques dans le pays et au développement rapide de la recherche.

La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché qui ont un impact sur les tendances actuelles et futures du marché. Les points de données, tels que les ventes de produits neufs et de remplacement, la démographie des pays, l'épidémiologie des maladies et les tarifs d'importation et d'exportation, sont quelques-uns des principaux indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la forte concurrence des marques locales et nationales, ainsi que l'impact des canaux de vente sont pris en compte lors de l'analyse prévisionnelle des données nationales.

Analyse du paysage concurrentiel et des parts de marché de la chirurgie du cancer du poumon

Le paysage concurrentiel du marché européen de la chirurgie du cancer du poumon fournit des détails par concurrents. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit et la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises sur le marché de la chirurgie du cancer du poumon.

Français Certains des principaux acteurs opérant sur le marché de la chirurgie du cancer du poumon sont AngioDynamics, Ackermann, Scanlan International, KLS Martin Group, Wexler Surgical, Lepu Medical Technology(Beijing) Co., Ltd., Intuitive Surgical, FusionKraft, Surgical Holdings, GerMedUSA, Medtronic, Accuray Incorporated, Teleflex Incorporated, KARL STORZ SE & Co. KG, TROKAMED GmbH, Richard Wolf GmbH, Sontec Instruments, Inc., asap endoscopic products GmbH, FUJIFILM Holdings America Corporation, Ambu A/S., Johnson & Johnson Services, Inc., Olympus Corporation et entre autres.

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. Les données du marché sont analysées et estimées à l'aide de modèles statistiques et cohérents du marché. En outre, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. La principale méthodologie de recherche utilisée par l'équipe de recherche DBMR est la triangulation des données, qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). En dehors de cela, les modèles de données comprennent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse des parts de marché Europe vs. Région et fournisseur. Veuillez demander un appel d'analyste en cas de demande de renseignements supplémentaires.


SKU-

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

  • Tableau de bord d'analyse de données interactif
  • Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
  • Accès d'analyste de recherche pour la personnalisation et les requêtes
  • Analyse de la concurrence avec tableau de bord interactif
  • Dernières actualités, mises à jour et analyse des tendances
  • Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Demande de démonstration

Table des matières

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE EUROPE LUNG CANCER SURGERY MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHIC SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 MULTIVARIATE MODELLING

2.8 PRODUCT TYPE LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 MARKET APPLICATION COVERAGE GRID

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL

4.2 PORTER'S FIVE FORCES MODEL

5 EPIDEMIOLOGY

5.1 INCIDENCE OF LUNG CANCER, BY COUNTRY

5.2 TREATMENT RATE BY GENDER

5.3 MORTALITY BY GENDER

6 REGULATIONS OF THE EUROPE LUNG CANCER SURGERY MARKET

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASED PREVALENCE OF LUNG CANCER DISEASES

7.1.2 TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF HEALTHCARE

7.1.3 INCREASED AWARENESS REGARDING THE BENEFITS

7.1.4 GOVERNMENT INITIATIVES TO IMPLEMENT SCREENING PROGRAMS FOR VARIOUS DISEASES

7.1.5 RISE IN AIR POLLUTION AND SURGE IN SMOKING

7.2 RESTRAINTS

7.2.1 HIGH COST OF LUNG CANCER SURGERY

7.2.2 INSUFFICIENT FUNDING FOR CANCER AND ASSOCIATED DISORDERS

7.2.3 STRINGENT REGULATORY FRAMEWORKS

7.3 OPPORTUNITIES

7.3.1 RISE OF MINIMALLY INVASIVE TECHNIQUES IN LUNG CANCER SURGERY

7.3.2 STRATEGIC INITIATIVES OF KEY PLAYERS

7.3.3 INCREASE IN RESEARCH AND DEVELOPMENT EFFORTS IN THE HEALTHCARE INDUSTRY

7.4 CHALLENGES

7.4.1 DEARTH OF SKILLED ONCOLOGISTS

7.4.2 HEALTH RISK OF LUNG CANCER SURGERIES

8 EUROPE LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE

8.1 OVERVIEW

8.2 SURGICAL INSTRUMENTS

8.2.1 HAND INSTRUMENTS

8.2.1.1 STAPLER

8.2.1.2 FORCEPS

8.2.1.3 ELECTRIC HOOK

8.2.1.4 RETRACTORS

8.2.1.5 CLAMPS

8.2.1.6 SCISSORS

8.2.1.7 ELEVATORS

8.2.1.8 HEMOCLIP APPLIERS

8.2.1.9 ULTRASOUND SCALPEL

8.2.1.10 RIB SHEARS

8.2.1.11 CUTTERS

8.2.1.12 NEEDLE HOLDER

8.2.1.13 TROCAR

8.2.1.14 OTHERS

8.2.2 POWERED SURGICAL EQUIPMENT

8.2.2.1 ADVANCED ENERGY INSTRUMENTS

8.2.2.1.1 ADVANCED BIPOLAR INSTRUMENTS

8.2.2.1.2 OTHERS

8.2.2.2 BASIC ENERGY INSTRUMENTS

8.2.2.2.1 BIPOLAR INSTRUMENTS

8.2.2.2.2 MONOPOLAR INSTRUMENTS

8.3 MONITORING & VISUALISING SYSTEM

8.3.1 CAMERAS & VIDEO SUPPORT

8.3.2 BRONCHOSCOPES

8.3.3 ENDOSCOPIC TROCARS WITH OPTICAL VIEWS

8.3.4 THORACOSCOPES

8.3.5 MEDIASTINOSCOPES

8.3.6 OTHERS

8.4 ENDOSURGICAL EQUIPMENTS

8.5 ROBOTIC ASSISTED SURGERY SYSTEMS

8.6 OTHERS

9 EUROPE LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE

9.1 OVERVIEW

9.2 THORACOTOMY

9.2.1 LOBECTOMY

9.2.1.1 SURGICAL INSTRUMENTS

9.2.1.2 MONITORING & VISUALISING SYSTEMS

9.2.1.3 ENDOSURGICAL EQUIPMENT

9.2.1.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS

9.2.1.5 OTHERS

9.2.2 SLEEVE RESECTION

9.2.2.1 SURGICAL INSTRUMENTS

9.2.2.2 MONITORING & VISUALISING SYSTEMS

9.2.2.3 ENDOSURGICAL EQUIPMENT

9.2.2.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS

9.2.2.5 OTHERS

9.2.3 SEGMENTECTOMY

9.2.3.1 SURGICAL INSTRUMENTS

9.2.3.2 MONITORING & VISUALISING SYSTEMS

9.2.3.3 ENDOSURGICAL EQUIPMENT

9.2.3.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS

9.2.3.5 OTHERS

9.2.4 PNEUMONECTOMY

9.2.4.1 SURGICAL INSTRUMENTS

9.2.4.2 MONITORING & VISUALISING SYSTEMS

9.2.4.3 ENDOSURGICAL EQUIPMENT

9.2.4.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS

9.2.4.5 OTHERS

9.2.5 OTHERS

9.3 MINIMALLY INVASIVE SURGERIES

9.3.1 VIDEO-ASSISTED THORACIC SURGERY (VATS)

9.3.1.1 SURGICAL INSTRUMENTS

9.3.1.2 MONITORING & VISUALISING SYSTEMS

9.3.1.3 ENDOSURGICAL EQUIPMENT

9.3.1.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS

9.3.1.5 OTHERS

9.3.2 ROBOTICALLY-ASSISTED THORACIC SURGERY (RATS)

9.3.2.1 SURGICAL INSTRUMENTS

9.3.2.2 MONITORING & VISUALISING SYSTEMS

9.3.2.3 ENDOSURGICAL EQUIPMENT

9.3.2.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS

9.3.2.5 OTHERS

10 EUROPE LUNG CANCER SURGERY MARKET, BY PATIENT TYPE

10.1 OVERVIEW

10.2 MALE

10.2.1 GERIATRIC

10.2.1.1 THORACOTOMY

10.2.1.2 MINIMALLY INVASIVE SURGERIES

10.2.2 ADULTS

10.2.2.1 THORACOTOMY

10.2.2.2 MINIMALLY INVASIVE SURGERIES

10.2.3 PEDIATRIC

10.2.3.1 THORACOTOMY

10.2.3.2 MINIMALLY INVASIVE SURGERIES

10.3 FEMALE

10.3.1 GERIATRIC

10.3.1.1 THORACOTOMY

10.3.1.2 MINIMALLY INVASIVE SURGERIES

10.3.2 ADULTS

10.3.2.1 THORACOTOMY

10.3.2.2 MINIMALLY INVASIVE SURGERIES

10.3.3 PEDIATRIC

10.3.3.1 THORACOTOMY

10.3.3.2 MINIMALLY INVASIVE SURGERIES

11 EUROPE LUNG CANCER SURGERY MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 DIRECT TENDER

11.3 RETAIL SALES

11.4 ONLINE SALES

11.5 OTHERS

12 EUROPE LUNG CANCER SURGERY MARKET, BY END USER

12.1 OVERVIEW

12.2 HOSPITALS

12.2.1 PUBLIC HOSPITALS

12.2.2 PRIVATE HOSPITALS

12.3 AMBULATORY SURGICAL CENTERS

12.4 SPECIALTY CANCER CARE CENTERS

12.5 ACADEMIC AND RESEARCH LABORATORIES

12.6 OTHERS

13 EUROPE LUNG CANCER SURGERY MARKET, BY REGION

13.1 EUROPE

13.1.1 GERMANY

13.1.2 FRANCE

13.1.3 U.K.

13.1.4 ITALY

13.1.5 SPAIN

13.1.6 RUSSIA

13.1.7 TURKEY

13.1.8 BELGIUM

13.1.9 NETHERLANDS

13.1.10 SWITZERLAND

13.1.11 REST OF EUROPE

14 EUROPE LUNG CANCER SURGERY MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: EUROPE

15 SWOT ANALYSIS

16 COMPANY PROFILES

16.1 JOHNSON & JOHNSON SERVICES, INC.

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.5 RECENT DEVELOPMENTS

16.2 ACCURAY INCORPORATED

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 PRODUCT PORTFOLIO

16.2.5 RECENT DEVELOPMENTS

16.3 INTUITIVE SURGICAL

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 COMPANY SHARE ANALYSIS

16.3.4 PRODUCT PORTFOLIO

16.3.5 RECENT DEVELOPMENTS

16.4 FUJIFILM HOLDINGS CORPORATION

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 COMPANY SHARE ANALYSIS

16.4.4 PRODUCT PORTFOLIO

16.4.5 RECENT DEVELOPMENTS

16.5 AMBU A/S.

16.5.1 COMPANY SNAPSHOT

16.5.2 REVENUE ANALYSIS

16.5.3 COMPANY SHARE ANALYSIS

16.5.4 PRODUCT PORTFOLIO

16.5.5 RECENT DEVELOPMENTS

16.6 ANGIODYNAMICS

16.6.1 COMPANY SNAPSHOT

16.6.2 REVENUE ANALYSIS

16.6.3 PRODUCT PORTFOLIO

16.6.4 RECENT DEVELOPMENT

16.7 ACKERMANN

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.3 RECENT DEVELOPMENTS

16.8 ASAP ENDOSCOPIC PRODUCTS GMBH

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCTPORTFOLIO

16.8.3 RECENT DEVELOPMENT

16.9 FUSIONKRAFT

16.9.1 COMPANY SNAPSHOT

16.9.2 PRODUCT PORTFOLIO

16.9.3 RECENT DEVELOPMENTS

16.1 GERMED USA

16.10.1 COMPANY SNAPSHOT

16.10.2 PRODUCT PORTFOLIO

16.10.3 RECENT DEVELOPMENTS

16.11 KLS MARTIN GROUP

16.11.1 COMPANY SNAPSHOT

16.11.2 PRODUCT PORTFOLIO

16.11.3 RECENT DEVELOPMENTS

16.12 KARL STORZ SE & CO. KG

16.12.1 COMPANY SNAPSHOT

16.12.2 PRODUCT PORTFOLIO

16.12.3 RECENT DEVELOPMENT

16.13 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.

16.13.1 COMPANY SNAPSHOT

16.13.2 PRODUCT PORTFOLIO

16.13.3 RECENT DEVELOPMENT

16.14 MEDTRONICS (2021)

16.14.1 COMPANY SNAPSHOT

16.14.2 REVENUE ANALYSIS

16.14.3 PRODUCT PORTFOLIO

16.14.4 RECENT DEVELOPMENT

16.15 OLYMPUS CORPORATION

16.15.1 COMPANY SNAPSHOT

16.15.2 REVENUE ANALYSIS

16.15.3 PRODUCTPORTFOLIO

16.15.4 RECENT DEVELOPMENTS

16.16 RICHARD WOLF GMBH.

16.16.1 COMPANY SNAPSHOT

16.16.2 PRODUCT PORTFOLIO

16.16.3 RECENT DEVELOPMENTS

16.17 SURGICAL HOLDINGS

16.17.1 COMPANY SNAPSHOT

16.17.2 PRODUCT PORTFOLIO

16.17.3 RECENT DEVELOPMENTS

16.18 SONTEC INSTRUMENTS, INC.

16.18.1 COMPANY SNAPSHOT

16.18.2 PRODUCT PORTFOLIO

16.18.3 RECENT DEVELOPMENT

16.19 SCANLAN INTERNATIONAL

16.19.1 COMPANY SNAPSHOT

16.19.2 PRODUCT PORTFOLIO

16.19.3 RECENT DEVELOPMENTS

16.2 TELEFLEX INCORPORATED

16.20.1 COMPANY SNAPSHOT

16.20.2 REVENUE ANALYSIS

16.20.3 PRODUCTPORTFOLIO

16.20.4 RECENT DEVELOPMENT

16.21 TROKAMED GMBH.

16.21.1 COMPANY SNAPSHOT

16.21.2 PRODUCT PORTFOLIO

16.21.3 RECENT DEVELOPMENT

16.22 WEXLER SURGICAL

16.22.1 COMPANY SNAPSHOT

16.22.2 PRODUCT PORTFOLIO

16.22.3 RECENT DEVELOPMENTS

17 QUESTIONNAIRE

18 RELATED REPORTS

Liste des tableaux

TABLE 1 THE BELOW TABLE SHOWS REGION-SPECIFIC INCIDENCE AGE-STANDARDIZED RATES PER 100,000 BY SEX FOR LUNG CANCER AMONG MEN AND WOMEN IN 2020

TABLE 2 EUROPE LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 3 EUROPE SURGICAL INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 4 EUROPE SURGICAL INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 5 EUROPE HAND INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 6 EUROPE HAND INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME IN THOUSAND UNITS)

TABLE 7 EUROPE POWERED SURGICAL EQUIPMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 8 EUROPE ADVANCED ENERGY INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 9 EUROPE BASIC ENERGY INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 10 EUROPE BASIC ENERGY INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (VOLUME IN THOUSAND UNITS)

TABLE 11 EUROPE MONITORING & VISUALISING SYSTEMS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 EUROPE MONITORING & VISUALISING SYSTEMS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 13 EUROPE MONITORING & VISUALISING SYSTEMS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME IN THOUSAND UNITS)

TABLE 14 EUROPE ENDOSURGICAL EQUIPMENT IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 15 EUROPE ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 EUROPE OTHERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 EUROPE LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)

TABLE 18 EUROPE THORACOTOMY IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 EUROPE THORACOTOMY IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 20 EUROPE LOBECTOMY IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 21 EUROPE SLEEVE RESECTION IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 22 EUROPE SEGMENTECTOMY IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 23 EUROPE PNEUMONECTOMY IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 24 EUROPE MINIMALLY INVASIVE SURGERIES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 EUROPE MINIMALLY INVASIVE SURGERIES IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 26 EUROPE VIDEO-ASSISTED THORACIC SURGERY (VATS) IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 27 EUROPE ROBOTICALLY-ASSISTED THORACIC SURGERY (RATS) IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 28 EUROPE LUNG CANCER SURGERY MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 29 EUROPE MALE IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 EUROPE MALE IN LUNG CANCER SURGERY MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 31 EUROPE GERIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)

TABLE 32 EUROPE ADULTS IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)

TABLE 33 EUROPE PEDIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)

TABLE 34 EUROPE FEMALE IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 EUROPE FEMALE IN LUNG CANCER SURGERY MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 36 EUROPE GERIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)

TABLE 37 EUROPE ADULTS IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)

TABLE 38 EUROPE PEDIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)

TABLE 39 EUROPE LUNG CANCER SURGERY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 40 EUROPE DIRECT TENDER IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 EUROPE RETAIL SALES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 42 EUROPE ONLINE SALES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 43 EUROPE ONLINE SALES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 44 EUROPE LUNG CANCER SURGERY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 45 EUROPE HOSPITALS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 46 EUROPE HOSPITALS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 47 EUROPE AMBULATORY SURGICAL CENTERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 48 EUROPE SPECIALTY CANCER CARE CENTERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 49 EUROPE ACADEMIC AND RESEARCH LABORATORIES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION))

TABLE 50 EUROPE OTHERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 51 EUROPE LUNG CANCER SURGERY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

Liste des figures

FIGURE 1 EUROPE LUNG CANCER SURGERYMARKET: SEGMENTATION

FIGURE 2 EUROPE LUNG CANCER SURGERY MARKET: GEOGRAPHIC SCOPE

FIGURE 3 EUROPE LUNG CANCER SURGERYMARKET: DATA TRIANGULATION

FIGURE 4 EUROPE LUNG CANCER SURGERY MARKET: SNAPSHOT

FIGURE 5 EUROPE LUNG CANCER SURGERY MARKET: BOTTOM UP APPROACH

FIGURE 6 EUROPE LUNG CANCER SURGERY MARKET: TOP DOWN APPROACH

FIGURE 7 EUROPE LUNG CANCER SURGERY MARKET: INTERVIEWS BY REGION AND DESIGNATION

FIGURE 8 EUROPE LUNG CANCER SURGERY MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE LUNG CANCER SURGERY MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE LUNG CANCER SURGERY MARKET: END USER COVERAGE GRID

FIGURE 11 EUROPE LUNG CANCER SURGERY MARKET SEGMENTATION

FIGURE 12 GROWING PREVALENCE OF CANCER DISEASES, RISE IN AIR POLLUTION, AND SURGE IN SMOKING HABIT IS EXPECTED TO DRIVE THE EUROPE LUNG CANCER SURGERY MARKET GROWTH IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 13 SURGICAL INSTRUMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE LUNG CANCER SURGERY MARKET IN 2022 & 2029

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF EUROPE LUNG CANCER SURGERY MARKET

FIGURE 15 EUROPE LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, 2021

FIGURE 16 EUROPE LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION)

FIGURE 17 EUROPE LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, CAGR (2022-2029)

FIGURE 18 EUROPE LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 19 EUROPE LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, 2021

FIGURE 20 EUROPE LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, 2022-2029 (USD MILLION)

FIGURE 21 EUROPE LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, CAGR (2022-2029)

FIGURE 22 EUROPE LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, LIFELINE CURVE

FIGURE 23 EUROPE LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, 2021

FIGURE 24 EUROPE LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, 2022-2029 (USD MILLION)

FIGURE 25 EUROPE LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, CAGR (2022-2029)

FIGURE 26 EUROPE LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, LIFELINE CURVE

FIGURE 27 EUROPE LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 28 EUROPE LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

FIGURE 29 EUROPE LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 30 EUROPE LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 31 EUROPE LUNG CANCER SURGERY MARKET: BY END USER, 2021

FIGURE 32 EUROPE LUNG CANCER SURGERY MARKET: BY END USER, 2022-2029 (USD MILLION)

FIGURE 33 EUROPE LUNG CANCER SURGERY MARKET: BY END USER, CAGR (2022-2029)

FIGURE 34 EUROPE LUNG CANCER SURGERY MARKET: BY END USER, LIFELINE CURVE

FIGURE 35 EUROPE LUNG CANCER SURGERY MARKET: SNAPSHOT (2021)

FIGURE 36 EUROPE LUNG CANCER SURGERY MARKET: BY COUNTRY (2021)

FIGURE 37 EUROPE LUNG CANCER SURGERY MARKET: BY COUNTRY (2022 & 2029)

FIGURE 38 EUROPE LUNG CANCER SURGERY MARKET: BY COUNTRY (2021 & 2029)

FIGURE 39 EUROPE LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE (2022-2029)

FIGURE 40 EUROPE LUNG CANCER SURGERY MARKET: COMPANY SHARE 2021 (%)

Voir les informations détaillées Right Arrow

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.

Questions fréquemment posées

The Europe Lung Cancer Surgery Market size will be worth USD 1,356.92 million by 2029.
The Europe Lung Cancer Surgery Market growth rate will be 5.0% by 2029.
Increased Prevalence Of Lung Cancer Diseases & Technological Advancement In The Field Of Healthcare are the growth drivers of the Europe Lung Cancer Surgery Market.
The product type, surgical procedure, patient type, end user, and distribution channel are the factors on which the Europe Lung Cancer Surgery Market research is based.
The major companies in the Europe Lung Cancer Surgery Market are AngioDynamics, Ackermann, Scanlan International, KLS Martin Group, Wexler Surgical, Lepu Medical Technology(Beijing) Co., Ltd. , Intuitive Surgical, FusionKraft, Surgical Holdings, GerMedUSA, Medtronic, Accuray Incorporated, Teleflex Incorporated, KARL STORZ SE & Co. KG, TROKAMED GmbH, Richard Wolf GmbH, Sontec Instruments, Inc., asap endoscopic products GmbH, FUJIFILM Holdings America Corporation.